In summary, our data clearly demonstrate that postnatal ketanserin treatment prevents the emergence of anxiety following MS, and along with prior results, strongly link perturbed 5-HT2 receptor function following MS to the establishment of susceptibility for adult anxiety. The gene discussed is HTR2A; the disease is myeloid sarcoma.